DIMENSIONAL FUND ADVISORS LP - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 84 filers reported holding ENZO BIOCHEM INC in Q3 2020. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$1,180,257
-49.4%
843,086
-33.5%
0.00%
-100.0%
Q2 2023$2,331,674
-36.9%
1,267,075
-16.7%
0.00%0.0%
Q1 2023$3,697,381
+160029.1%
1,521,683
-5.7%
0.00%0.0%
Q4 2022$2,309
-99.9%
1,614,450
+1.3%
0.00%0.0%
Q3 2022$3,554,000
+7.1%
1,593,865
-0.5%
0.00%0.0%
Q2 2022$3,317,000
-28.3%
1,602,375
+0.5%
0.00%0.0%
Q1 2022$4,624,000
-9.8%
1,594,541
-0.1%
0.00%
-50.0%
Q4 2021$5,126,000
-6.8%
1,596,839
+2.7%
0.00%0.0%
Q3 2021$5,502,000
+8.9%
1,554,149
-2.5%
0.00%0.0%
Q2 2021$5,053,000
-10.1%
1,594,061
-2.4%
0.00%0.0%
Q1 2021$5,618,000
+30.8%
1,633,223
-4.1%
0.00%0.0%
Q4 2020$4,294,000
+5.8%
1,703,788
-11.4%
0.00%0.0%
Q3 2020$4,058,000
-7.7%
1,923,366
-2.0%
0.00%0.0%
Q2 2020$4,396,000
-15.9%
1,962,709
-5.0%
0.00%
-33.3%
Q1 2020$5,228,000
-6.6%
2,066,365
-2.9%
0.00%
+50.0%
Q4 2019$5,597,000
-27.5%
2,128,200
-0.7%
0.00%
-33.3%
Q3 2019$7,715,000
+7.0%
2,142,985
+0.1%
0.00%0.0%
Q2 2019$7,213,000
+25.6%
2,140,479
+1.7%
0.00%
+50.0%
Q1 2019$5,745,000
+1.8%
2,104,448
+3.7%
0.00%
-33.3%
Q4 2018$5,643,000
-32.9%
2,030,043
-0.6%
0.00%0.0%
Q3 2018$8,415,000
-19.0%
2,042,601
+2.0%
0.00%
-25.0%
Q2 2018$10,393,000
-6.1%
2,002,571
-0.8%
0.00%
-20.0%
Q1 2018$11,068,000
-35.1%
2,019,650
-3.4%
0.01%
-28.6%
Q4 2017$17,042,000
-24.2%
2,090,963
-2.7%
0.01%
-30.0%
Q3 2017$22,490,000
+0.5%
2,148,017
+6.0%
0.01%0.0%
Q2 2017$22,376,000
+45.8%
2,026,647
+10.5%
0.01%
+42.9%
Q1 2017$15,345,000
+17.2%
1,833,401
-2.8%
0.01%0.0%
Q4 2016$13,093,000
+35.9%
1,886,532
-0.3%
0.01%
+40.0%
Q3 2016$9,635,000
-11.0%
1,892,842
+4.4%
0.01%
-16.7%
Q2 2016$10,829,000
+41.6%
1,813,930
+7.9%
0.01%
+20.0%
Q1 2016$7,647,000
+11.1%
1,680,645
+9.9%
0.01%
+25.0%
Q4 2015$6,882,000
+39.6%
1,529,369
-1.7%
0.00%
+33.3%
Q3 2015$4,930,000
-5.4%
1,555,096
-9.6%
0.00%0.0%
Q2 2015$5,210,000
-2.0%
1,719,631
-4.6%
0.00%0.0%
Q1 2015$5,316,000
-36.6%
1,802,080
-4.6%
0.00%
-50.0%
Q4 2014$8,383,000
-15.7%
1,888,054
-2.2%
0.01%
-14.3%
Q3 2014$9,944,000
-2.3%
1,930,764
-0.4%
0.01%0.0%
Q2 2014$10,180,000
+24.9%
1,939,198
-1.0%
0.01%
+16.7%
Q1 2014$8,150,000
+41.7%
1,959,141
-0.5%
0.01%
+50.0%
Q4 2013$5,751,000
+15.8%
1,969,685
-0.0%
0.00%0.0%
Q3 2013$4,966,000
+20.5%
1,970,616
-0.5%
0.00%0.0%
Q2 2013$4,121,0001,981,4530.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2020
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 3,312,792$22,991,0004.49%
First Light Asset Management, LLC 1,007,357$6,991,0003.07%
KOPP INVESTMENT ADVISORS LLC 211,974$1,471,0001.55%
GLOBEFLEX CAPITAL L P 223,931$1,554,0000.39%
Nine Chapters Capital Management LLC 30,900$214,0000.36%
KEMPNER CAPITAL MANAGEMENT INC. 70,001$486,0000.35%
Campbell & CO Investment Adviser LLC 11,513$80,0000.25%
EAM Investors, LLC 259,914$1,804,0000.24%
Teza Capital Management LLC 14,636$102,0000.14%
Acrospire Investment Management LLC 46,220$321,0000.13%
View complete list of ENZO BIOCHEM INC shareholders